• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.95% Nasdaq Down 2.40%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    115.46 Down 4.04(3.38%) Jun 29, 4:00PM EDT
    Add to Portfolio
    Prev Close:119.50
    Open:117.95
    Bid:115.90 x 100
    Ask:116.63 x 100
    1y Target Est:122.00
    Beta:0.87
    Next Earnings Date:27-Jul-15GILD Earnings announcement
    Day's Range:115.30 - 119.14
    52wk Range:83.32 - 123.37
    Volume:12,491,082
    Avg Vol (3m):11,029,400
    Market Cap:169.67B
    P/E (ttm):13.16
    EPS (ttm):8.77
    Div & Yield:1.72 (1.40%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 3.38%169.67B
    GSKDown 2.01%101.50B
    PFEDown 0.97%206.84B
    RHHBYDown 2.31%N/A

    Key Statistics

    Forward P/E (1 yr):10.46
    P/S (ttm):6.39
    Ex-Dividend Date:12-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :10.77
    Quarterly EPS Est (Jun-15) :2.64
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.85

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback